Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-11

AUTHORS

Howard L. Kaufman, Lawrence H. Schwartz, William N. William, Mario Sznol, Kyle Fahrbach, Yingxin Xu, Eric Masson, Andrea Vergara-Silva

ABSTRACT

PURPOSE: Classical clinical endpoints [e.g., objective response rate (ORR), disease control rate (DCR), and progression-free survival (PFS)] may not be appropriate for immune checkpoint blockers (ICBs). We evaluated correlations between these endpoints and overall survival (OS) for surrogacy. METHODS: Randomized controlled trials (RCTs) of solid tumors patients treated with ICBs published between 01/2005 and 03/2017, and congress proceedings (2014-2016) were included. Arm-level analyses measured 6-month PFS rate to predict 18-month OS rate. Comparison-level analyses measured ORR odds ratio (OR), DCR OR, and 6-month PFS hazard ratio (HR) to predict OS HR. A pooled analysis for single-agent ICBs and ICBs plus chemotherapy vs chemotherapy was conducted. Studies of single-agent ICBs vs chemotherapy were separately analyzed. RESULTS: 27 RCTs involving 61 treatment arms and 10,300 patients were included. Arm-level analysis showed higher 6- or 9-month PFS rates predicted better 18-month OS rates for ICB arms and/or chemotherapy arms. ICB arms had a higher average OS rate vs chemotherapy for all PFS rates. Comparison-level analysis showed a nonsignificant/weak correlation between ORR OR (adjusted R2 = - 0.069; P = 0.866) or DCR OR (adjusted R2 = 0.271; P = 0.107) and OS HR. PFS HR correlated weakly with OS HR in the pooled (adjusted R2 = 0.366; P = 0.005) and single-agent (adjusted R2 = 0.452; P = 0.005) ICB studies. Six-month PFS HR was highly predictive of OS HR for single-agent ICBs (adjusted R2 = 0.907; P < 0.001), but weakly predictive in the pooled analysis (adjusted R2 = 0.333; P = 0.023). CONCLUSIONS: PFS was an imperfect surrogate for OS. Predictive value of 6-month PFS HR for OS HR in the single-agent ICB analysis requires further exploration. More... »

PAGES

2245-2261

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00432-018-2738-x

DOI

http://dx.doi.org/10.1007/s00432-018-2738-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106281720

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30132118


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endpoint Determination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Targeted Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Massachusetts General Hospital, 55 Fruit St Gray 730, Boston, MA, USA", 
            "Replimune Inc., 18 Commerce Way, 01801, Woburn, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaufman", 
        "givenName": "Howard L.", 
        "id": "sg:person.01333264012.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333264012.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, 622 W 168th St, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schwartz", 
        "givenName": "Lawrence H.", 
        "id": "sg:person.011027760412.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011027760412.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Benefic\u00eancia Portuguesa de S\u00e3o Paulo", 
          "id": "https://www.grid.ac/institutes/grid.414374.1", 
          "name": [
            "MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, USA", 
            "Centro Oncol\u00f3gico BP, a Benefic\u00eancia Portuguesa de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "William", 
        "givenName": "William N.", 
        "id": "sg:person.01262777171.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262777171.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yale University", 
          "id": "https://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Yale School of Medicine, 333 Cedar St, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sznol", 
        "givenName": "Mario", 
        "id": "sg:person.0706626451.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706626451.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmaceutical Product Development (United States)", 
          "id": "https://www.grid.ac/institutes/grid.423257.5", 
          "name": [
            "Evidera, 7101 Wisconsin Ave, Suite 1400, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fahrbach", 
        "givenName": "Kyle", 
        "id": "sg:person.01172723623.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172723623.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Regeneron (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418961.3", 
          "name": [
            "Evidera, 7101 Wisconsin Ave, Suite 1400, Bethesda, MD, USA", 
            "Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xu", 
        "givenName": "Yingxin", 
        "id": "sg:person.0740106667.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740106667.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biogen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417832.b", 
          "name": [
            "AstraZeneca, 35 Gatehouse Dr, Waltham, MA, USA", 
            "Biogen, 225 Binney St, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masson", 
        "givenName": "Eric", 
        "id": "sg:person.014363567577.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014363567577.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "AstraZeneca, One MedImmune Way, Gaithersburg, MD, USA", 
            "Ayala Pharmaceuticals, 1313 N. Market Str, Suite 5100, Wilmington, DE, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vergara-Silva", 
        "givenName": "Andrea", 
        "id": "sg:person.011534576530.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011534576530.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1507643", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000663586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30366-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001468571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30126-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002679693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-9-204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002969174", 
          "https://doi.org/10.1186/1479-5876-9-204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.38.4032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005959156"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(16)00587-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006558153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2288-12-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010370832", 
          "https://doi.org/10.1186/1471-2288-12-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2014.13943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011226192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1412082", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012352031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012633605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1503093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014234053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.44.6112", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015465321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-09-1024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016716683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1510665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019970557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-009-9376-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021055401", 
          "https://doi.org/10.1007/s10637-009-9376-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamainternmed.2015.2829", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022764672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25526", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023451811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(15)01281-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023503843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2008.10.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026558254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-09-1624", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028571226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31823735d6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031194485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cji.0b013e31823735d6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031194485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(16)32517-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033503380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-13-0895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033750005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.38.7571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033934691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1104621", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036355137"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1602252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036710957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2288-11-139", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037378478", 
          "https://doi.org/10.1186/1471-2288-11-139"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1606774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037631694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.56.6018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038163219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30498-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043568396"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)70007-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047673016"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1504627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052572745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70334-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053423975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.08.072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2015.64.0391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.19.3390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074706769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdw379.04", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083559540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdw435.39", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083560068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1613683", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083846671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(17)30074-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084052467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaoncol.2017.1029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086044314"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12916-017-0902-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090559553", 
          "https://doi.org/10.1186/s12916-017-0902-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12916-017-0902-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090559553", 
          "https://doi.org/10.1186/s12916-017-0902-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s40425-017-0276-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091624031", 
          "https://doi.org/10.1186/s40425-017-0276-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/2159-8290.cd-nd2017-006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092132792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdx440.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092171969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.34.15_suppl.9028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106842751"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-11", 
    "datePublishedReg": "2018-11-01", 
    "description": "PURPOSE: Classical clinical endpoints [e.g., objective response rate (ORR), disease control rate (DCR), and progression-free survival (PFS)] may not be appropriate for immune checkpoint blockers (ICBs). We evaluated correlations between these endpoints and overall survival (OS) for surrogacy.\nMETHODS: Randomized controlled trials (RCTs) of solid tumors patients treated with ICBs published between 01/2005 and 03/2017, and congress proceedings (2014-2016) were included. Arm-level analyses measured 6-month PFS rate to predict 18-month OS rate. Comparison-level analyses measured ORR odds ratio (OR), DCR OR, and 6-month PFS hazard ratio (HR) to predict OS HR. A pooled analysis for single-agent ICBs and ICBs plus chemotherapy vs chemotherapy was conducted. Studies of single-agent ICBs vs chemotherapy were separately analyzed.\nRESULTS: 27 RCTs involving 61 treatment arms and 10,300 patients were included. Arm-level analysis showed higher 6- or 9-month PFS rates predicted better 18-month OS rates for ICB arms and/or chemotherapy arms. ICB arms had a higher average OS rate vs chemotherapy for all PFS rates. Comparison-level analysis showed a nonsignificant/weak correlation between ORR OR (adjusted R2\u2009=\u2009-\u20090.069; P\u2009=\u20090.866) or DCR OR (adjusted R2\u2009=\u20090.271; P\u2009=\u20090.107) and OS HR. PFS HR correlated weakly with OS HR in the pooled (adjusted R2\u2009=\u20090.366; P\u2009=\u20090.005) and single-agent (adjusted R2\u2009=\u20090.452; P\u2009=\u20090.005) ICB studies. Six-month PFS HR was highly predictive of OS HR for single-agent ICBs (adjusted R2\u2009=\u20090.907; P\u2009<\u20090.001), but weakly predictive in the pooled analysis (adjusted R2\u2009=\u20090.333; P\u2009=\u20090.023).\nCONCLUSIONS: PFS was an imperfect surrogate for OS. Predictive value of 6-month PFS HR for OS HR in the single-agent ICB analysis requires further exploration.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00432-018-2738-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "144"
      }
    ], 
    "name": "Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis", 
    "pagination": "2245-2261", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e42d4d8d47f71b2d7b11fa1f75f663d6baf5b93b2daed6510f6380dc4167066c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30132118"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00432-018-2738-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106281720"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00432-018-2738-x", 
      "https://app.dimensions.ai/details/publication/pub.1106281720"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000578.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00432-018-2738-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00432-018-2738-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00432-018-2738-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00432-018-2738-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00432-018-2738-x'


 

This table displays all metadata directly associated to this object as RDF triples.

315 TRIPLES      21 PREDICATES      82 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00432-018-2738-x schema:about N52e264872bba45ddbd23af1467f25c9d
2 N53268322346f425abcf4ac2f82b17350
3 N82f2eddafc1649f898cb27bb1e4ace65
4 N85d63a70280048909699d9f99663b51f
5 N9967067023014437b1b54af911cf7526
6 Nd1c64db156df40eab3d94f7e3c714d0b
7 Nea89ba1abf3a49ef8a5d96f26d31d26d
8 anzsrc-for:11
9 anzsrc-for:1112
10 schema:author Nadc5fb999ae747cdb18032bc0dfdc052
11 schema:citation sg:pub.10.1007/s10637-009-9376-8
12 sg:pub.10.1186/1471-2288-11-139
13 sg:pub.10.1186/1471-2288-12-9
14 sg:pub.10.1186/1479-5876-9-204
15 sg:pub.10.1186/s12916-017-0902-9
16 sg:pub.10.1186/s40425-017-0276-8
17 https://doi.org/10.1001/jama.2014.13943
18 https://doi.org/10.1001/jamainternmed.2015.2829
19 https://doi.org/10.1001/jamaoncol.2017.1029
20 https://doi.org/10.1002/cncr.25526
21 https://doi.org/10.1016/j.ejca.2008.10.026
22 https://doi.org/10.1016/s0140-6736(15)01281-7
23 https://doi.org/10.1016/s0140-6736(16)00587-0
24 https://doi.org/10.1016/s0140-6736(16)32517-x
25 https://doi.org/10.1016/s1470-2045(09)70334-1
26 https://doi.org/10.1016/s1470-2045(14)70007-5
27 https://doi.org/10.1016/s1470-2045(16)30126-7
28 https://doi.org/10.1016/s1470-2045(16)30366-7
29 https://doi.org/10.1016/s1470-2045(16)30498-3
30 https://doi.org/10.1016/s1470-2045(17)30074-8
31 https://doi.org/10.1056/nejmoa1104621
32 https://doi.org/10.1056/nejmoa1412082
33 https://doi.org/10.1056/nejmoa1503093
34 https://doi.org/10.1056/nejmoa1504627
35 https://doi.org/10.1056/nejmoa1507643
36 https://doi.org/10.1056/nejmoa1510665
37 https://doi.org/10.1056/nejmoa1602252
38 https://doi.org/10.1056/nejmoa1606774
39 https://doi.org/10.1056/nejmoa1613683
40 https://doi.org/10.1093/annonc/mdv617
41 https://doi.org/10.1093/annonc/mdw379.04
42 https://doi.org/10.1093/annonc/mdw435.39
43 https://doi.org/10.1093/annonc/mdx440.029
44 https://doi.org/10.1097/cji.0b013e31823735d6
45 https://doi.org/10.1158/1078-0432.ccr-09-1024
46 https://doi.org/10.1158/1078-0432.ccr-09-1624
47 https://doi.org/10.1158/1078-0432.ccr-13-0895
48 https://doi.org/10.1158/2159-8290.cd-nd2017-006
49 https://doi.org/10.1200/jco.2000.18.19.3390
50 https://doi.org/10.1200/jco.2003.08.072
51 https://doi.org/10.1200/jco.2011.38.4032
52 https://doi.org/10.1200/jco.2011.38.7571
53 https://doi.org/10.1200/jco.2012.44.6112
54 https://doi.org/10.1200/jco.2014.56.6018
55 https://doi.org/10.1200/jco.2015.64.0391
56 https://doi.org/10.1200/jco.2016.34.15_suppl.9028
57 schema:datePublished 2018-11
58 schema:datePublishedReg 2018-11-01
59 schema:description PURPOSE: Classical clinical endpoints [e.g., objective response rate (ORR), disease control rate (DCR), and progression-free survival (PFS)] may not be appropriate for immune checkpoint blockers (ICBs). We evaluated correlations between these endpoints and overall survival (OS) for surrogacy. METHODS: Randomized controlled trials (RCTs) of solid tumors patients treated with ICBs published between 01/2005 and 03/2017, and congress proceedings (2014-2016) were included. Arm-level analyses measured 6-month PFS rate to predict 18-month OS rate. Comparison-level analyses measured ORR odds ratio (OR), DCR OR, and 6-month PFS hazard ratio (HR) to predict OS HR. A pooled analysis for single-agent ICBs and ICBs plus chemotherapy vs chemotherapy was conducted. Studies of single-agent ICBs vs chemotherapy were separately analyzed. RESULTS: 27 RCTs involving 61 treatment arms and 10,300 patients were included. Arm-level analysis showed higher 6- or 9-month PFS rates predicted better 18-month OS rates for ICB arms and/or chemotherapy arms. ICB arms had a higher average OS rate vs chemotherapy for all PFS rates. Comparison-level analysis showed a nonsignificant/weak correlation between ORR OR (adjusted R2 = - 0.069; P = 0.866) or DCR OR (adjusted R2 = 0.271; P = 0.107) and OS HR. PFS HR correlated weakly with OS HR in the pooled (adjusted R2 = 0.366; P = 0.005) and single-agent (adjusted R2 = 0.452; P = 0.005) ICB studies. Six-month PFS HR was highly predictive of OS HR for single-agent ICBs (adjusted R2 = 0.907; P < 0.001), but weakly predictive in the pooled analysis (adjusted R2 = 0.333; P = 0.023). CONCLUSIONS: PFS was an imperfect surrogate for OS. Predictive value of 6-month PFS HR for OS HR in the single-agent ICB analysis requires further exploration.
60 schema:genre research_article
61 schema:inLanguage en
62 schema:isAccessibleForFree true
63 schema:isPartOf N40eb9e2429f34fb79de9b3641696fd2e
64 Na81def9866654e34bf886415d8163b30
65 sg:journal.1313647
66 schema:name Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis
67 schema:pagination 2245-2261
68 schema:productId N0244b9a8348c4827b0b4170cda80e5ce
69 N64a95bc3ea7b457687656eb66c0cb8d0
70 N94765ba8d5c44efba2a92b5a88e56d1a
71 Nb25bef58aaca457b97d86d2e7d195040
72 Nf7fc15a6e96b46d689af98921e83df4f
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106281720
74 https://doi.org/10.1007/s00432-018-2738-x
75 schema:sdDatePublished 2019-04-10T22:43
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher Na507017484fd48a48be6a5146a1ed3b0
78 schema:url https://link.springer.com/10.1007%2Fs00432-018-2738-x
79 sgo:license sg:explorer/license/
80 sgo:sdDataset articles
81 rdf:type schema:ScholarlyArticle
82 N0244b9a8348c4827b0b4170cda80e5ce schema:name nlm_unique_id
83 schema:value 7902060
84 rdf:type schema:PropertyValue
85 N0fba92b189e346f4bf1e65d924a2ea29 rdf:first sg:person.011027760412.07
86 rdf:rest Naafe51099d4c4d03b226c0ec08e9880c
87 N287374cbbb544a6aaf71c68270ec728a rdf:first sg:person.01172723623.69
88 rdf:rest Nc0a62b3c2c8b483fa83d5fe3e0a1d5f8
89 N2da51d8229044ebc9e0b97ec0017b3cf rdf:first sg:person.0706626451.72
90 rdf:rest N287374cbbb544a6aaf71c68270ec728a
91 N40eb9e2429f34fb79de9b3641696fd2e schema:volumeNumber 144
92 rdf:type schema:PublicationVolume
93 N45c0cf42cc7a4d00bdcbb3e710a9f4de rdf:first sg:person.014363567577.38
94 rdf:rest Nff1df7fc5b6046019a21db43d2737473
95 N52e264872bba45ddbd23af1467f25c9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Neoplasms
97 rdf:type schema:DefinedTerm
98 N53268322346f425abcf4ac2f82b17350 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Endpoint Determination
100 rdf:type schema:DefinedTerm
101 N64a95bc3ea7b457687656eb66c0cb8d0 schema:name readcube_id
102 schema:value e42d4d8d47f71b2d7b11fa1f75f663d6baf5b93b2daed6510f6380dc4167066c
103 rdf:type schema:PropertyValue
104 N82f2eddafc1649f898cb27bb1e4ace65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Survival Analysis
106 rdf:type schema:DefinedTerm
107 N85d63a70280048909699d9f99663b51f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Antineoplastic Agents
109 rdf:type schema:DefinedTerm
110 N94765ba8d5c44efba2a92b5a88e56d1a schema:name dimensions_id
111 schema:value pub.1106281720
112 rdf:type schema:PropertyValue
113 N9967067023014437b1b54af911cf7526 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Randomized Controlled Trials as Topic
115 rdf:type schema:DefinedTerm
116 Na507017484fd48a48be6a5146a1ed3b0 schema:name Springer Nature - SN SciGraph project
117 rdf:type schema:Organization
118 Na81def9866654e34bf886415d8163b30 schema:issueNumber 11
119 rdf:type schema:PublicationIssue
120 Naafe51099d4c4d03b226c0ec08e9880c rdf:first sg:person.01262777171.70
121 rdf:rest N2da51d8229044ebc9e0b97ec0017b3cf
122 Nadc5fb999ae747cdb18032bc0dfdc052 rdf:first sg:person.01333264012.85
123 rdf:rest N0fba92b189e346f4bf1e65d924a2ea29
124 Nb25bef58aaca457b97d86d2e7d195040 schema:name doi
125 schema:value 10.1007/s00432-018-2738-x
126 rdf:type schema:PropertyValue
127 Nc0a62b3c2c8b483fa83d5fe3e0a1d5f8 rdf:first sg:person.0740106667.02
128 rdf:rest N45c0cf42cc7a4d00bdcbb3e710a9f4de
129 Ncab9d10a136b4f84ae0ccfb0677ef5ac schema:name Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, 622 W 168th St, New York, NY, USA
130 rdf:type schema:Organization
131 Nd1c64db156df40eab3d94f7e3c714d0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 Nea89ba1abf3a49ef8a5d96f26d31d26d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Molecular Targeted Therapy
136 rdf:type schema:DefinedTerm
137 Nf7fc15a6e96b46d689af98921e83df4f schema:name pubmed_id
138 schema:value 30132118
139 rdf:type schema:PropertyValue
140 Nff1df7fc5b6046019a21db43d2737473 rdf:first sg:person.011534576530.49
141 rdf:rest rdf:nil
142 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
143 schema:name Medical and Health Sciences
144 rdf:type schema:DefinedTerm
145 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
146 schema:name Oncology and Carcinogenesis
147 rdf:type schema:DefinedTerm
148 sg:journal.1313647 schema:issn 0171-5216
149 1432-1335
150 schema:name Journal of Cancer Research and Clinical Oncology
151 rdf:type schema:Periodical
152 sg:person.011027760412.07 schema:affiliation Ncab9d10a136b4f84ae0ccfb0677ef5ac
153 schema:familyName Schwartz
154 schema:givenName Lawrence H.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011027760412.07
156 rdf:type schema:Person
157 sg:person.011534576530.49 schema:affiliation https://www.grid.ac/institutes/grid.418152.b
158 schema:familyName Vergara-Silva
159 schema:givenName Andrea
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011534576530.49
161 rdf:type schema:Person
162 sg:person.01172723623.69 schema:affiliation https://www.grid.ac/institutes/grid.423257.5
163 schema:familyName Fahrbach
164 schema:givenName Kyle
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172723623.69
166 rdf:type schema:Person
167 sg:person.01262777171.70 schema:affiliation https://www.grid.ac/institutes/grid.414374.1
168 schema:familyName William
169 schema:givenName William N.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262777171.70
171 rdf:type schema:Person
172 sg:person.01333264012.85 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
173 schema:familyName Kaufman
174 schema:givenName Howard L.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333264012.85
176 rdf:type schema:Person
177 sg:person.014363567577.38 schema:affiliation https://www.grid.ac/institutes/grid.417832.b
178 schema:familyName Masson
179 schema:givenName Eric
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014363567577.38
181 rdf:type schema:Person
182 sg:person.0706626451.72 schema:affiliation https://www.grid.ac/institutes/grid.47100.32
183 schema:familyName Sznol
184 schema:givenName Mario
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706626451.72
186 rdf:type schema:Person
187 sg:person.0740106667.02 schema:affiliation https://www.grid.ac/institutes/grid.418961.3
188 schema:familyName Xu
189 schema:givenName Yingxin
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740106667.02
191 rdf:type schema:Person
192 sg:pub.10.1007/s10637-009-9376-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021055401
193 https://doi.org/10.1007/s10637-009-9376-8
194 rdf:type schema:CreativeWork
195 sg:pub.10.1186/1471-2288-11-139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037378478
196 https://doi.org/10.1186/1471-2288-11-139
197 rdf:type schema:CreativeWork
198 sg:pub.10.1186/1471-2288-12-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010370832
199 https://doi.org/10.1186/1471-2288-12-9
200 rdf:type schema:CreativeWork
201 sg:pub.10.1186/1479-5876-9-204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002969174
202 https://doi.org/10.1186/1479-5876-9-204
203 rdf:type schema:CreativeWork
204 sg:pub.10.1186/s12916-017-0902-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090559553
205 https://doi.org/10.1186/s12916-017-0902-9
206 rdf:type schema:CreativeWork
207 sg:pub.10.1186/s40425-017-0276-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091624031
208 https://doi.org/10.1186/s40425-017-0276-8
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1001/jama.2014.13943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011226192
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1001/jamainternmed.2015.2829 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022764672
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1001/jamaoncol.2017.1029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086044314
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1002/cncr.25526 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023451811
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/j.ejca.2008.10.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026558254
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/s0140-6736(15)01281-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023503843
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/s0140-6736(16)00587-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006558153
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/s0140-6736(16)32517-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033503380
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/s1470-2045(09)70334-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053423975
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/s1470-2045(14)70007-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047673016
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/s1470-2045(16)30126-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002679693
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/s1470-2045(16)30366-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001468571
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s1470-2045(16)30498-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043568396
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s1470-2045(17)30074-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084052467
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1056/nejmoa1104621 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036355137
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1056/nejmoa1412082 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012352031
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1056/nejmoa1503093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014234053
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1056/nejmoa1504627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052572745
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1056/nejmoa1507643 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000663586
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1056/nejmoa1510665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019970557
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1056/nejmoa1602252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036710957
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1056/nejmoa1606774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037631694
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejmoa1613683 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083846671
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1093/annonc/mdv617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012633605
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1093/annonc/mdw379.04 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083559540
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1093/annonc/mdw435.39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083560068
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1093/annonc/mdx440.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092171969
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1097/cji.0b013e31823735d6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031194485
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1158/1078-0432.ccr-09-1024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016716683
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1158/1078-0432.ccr-09-1624 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028571226
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1158/1078-0432.ccr-13-0895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033750005
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1158/2159-8290.cd-nd2017-006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092132792
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2000.18.19.3390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074706769
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2003.08.072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203794
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2011.38.4032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005959156
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2011.38.7571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033934691
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2012.44.6112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015465321
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1200/jco.2014.56.6018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038163219
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1200/jco.2015.64.0391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204451
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1200/jco.2016.34.15_suppl.9028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106842751
289 rdf:type schema:CreativeWork
290 https://www.grid.ac/institutes/grid.32224.35 schema:alternateName Massachusetts General Hospital
291 schema:name Massachusetts General Hospital, 55 Fruit St Gray 730, Boston, MA, USA
292 Replimune Inc., 18 Commerce Way, 01801, Woburn, MA, USA
293 rdf:type schema:Organization
294 https://www.grid.ac/institutes/grid.414374.1 schema:alternateName Beneficência Portuguesa de São Paulo
295 schema:name Centro Oncológico BP, a Beneficência Portuguesa de São Paulo, São Paulo, Brazil
296 MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, USA
297 rdf:type schema:Organization
298 https://www.grid.ac/institutes/grid.417832.b schema:alternateName Biogen (United States)
299 schema:name AstraZeneca, 35 Gatehouse Dr, Waltham, MA, USA
300 Biogen, 225 Binney St, Cambridge, MA, USA
301 rdf:type schema:Organization
302 https://www.grid.ac/institutes/grid.418152.b schema:alternateName AstraZeneca (United States)
303 schema:name AstraZeneca, One MedImmune Way, Gaithersburg, MD, USA
304 Ayala Pharmaceuticals, 1313 N. Market Str, Suite 5100, Wilmington, DE, USA
305 rdf:type schema:Organization
306 https://www.grid.ac/institutes/grid.418961.3 schema:alternateName Regeneron (United States)
307 schema:name Evidera, 7101 Wisconsin Ave, Suite 1400, Bethesda, MD, USA
308 Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, USA
309 rdf:type schema:Organization
310 https://www.grid.ac/institutes/grid.423257.5 schema:alternateName Pharmaceutical Product Development (United States)
311 schema:name Evidera, 7101 Wisconsin Ave, Suite 1400, Bethesda, MD, USA
312 rdf:type schema:Organization
313 https://www.grid.ac/institutes/grid.47100.32 schema:alternateName Yale University
314 schema:name Yale School of Medicine, 333 Cedar St, New Haven, CT, USA
315 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...